We are live on
!
Find out more
BL
Bleichroeder LP Portfolio holdings
AUM
$559M
Turnover
17.24%
1-Year Est. Return
83.7%
This Fund
S&P 500
This Quarter
Est. Return
+14.86%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
–
AUM
$407M
AUM Growth
+$31.5M
(+8.4%)
Cap. Flow
-$10.4M
Cap. Flow
% of AUM
-2.56%
Top 10 Holdings %
Top 10 Hldgs %
81.6%
Holding
83
New
5
Increased
5
Reduced
5
Closed
7
Avg Time Held
3
years
Top 10 Avg Time Held
1.9
years
Top 20 Avg Time Held
2.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Precision BioSciences
DTIL
|
+$5.24M |
| 2 |
Welltower
WELL
|
+$2.99M |
| 3 |
NeuroOne Medical Technologies
NMTC
|
+$2.46M |
| 4 |
EyePoint Inc
EYPT
|
+$1.77M |
| 5 |
Cue Biopharma
CUE
|
+$1.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intevac Inc
IVAC
|
+$20.1M |
| 2 |
OptiNose
OPTN
|
+$2.47M |
| 3 |
SiriusXM
SIRI
|
+$1.32M |
| 4 |
A2Z Smart Technologies
AZ
|
+$706K |
| 5 |
Spire Global
SPIR
|
+$607K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.13% |
| 2 | Industrials | 20.15% |
| 3 | Healthcare | 12.49% |
| 4 | Materials | 9.71% |
| 5 | Financials | 7.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Sprott Physical Gold
PHYS
$14.9B
| $318K | 0.08% |
12,540
| – | – |
2019 Q4
22 quarters
|
|
52
Otis Worldwide
OTIS
$27B
| $297K | 0.07% |
3,000
| – | – |
2020 Q2
20 quarters
|
|
53
Structure Therapeutics
GPCR
$1.49B
| $207K | 0.05% |
10,000
| – | – |
2023 Q4
6 quarters
|
|
54
Talphera
TLPH
$56.1M
| $196K | 0.05% |
426,621
| – | – |
2025 Q1
1 quarter
|
|
55
Bank of New York Mellon
BNY
$96.6B
| $182K | 0.04% |
2,000
| – | – |
2020 Q1
21 quarters
|
|
56
DELISTED
Evoke Pharma
EVOK
| $179K | 0.04% |
68,750
| – | – |
2024 Q1
5 quarters
|
|
57
Cadence Design Systems
CDNS
$87.7B
| $162K | 0.04% |
525
| – | – |
2020 Q2
20 quarters
|
|
58
Beyond Air
XAIR
$2.16M
| $127K | 0.03% |
1,846
| – | – |
2024 Q3
3 quarters
|
|
|
59
SiriusXM
SIRI
$9.03B
| $116K | 0.03% |
5,061
-61,444
| -92% | -$1.32M |
2024 Q3
3 quarters
|
|
60
ExxonMobil
XOM
$732B
| $116K | 0.03% |
1,075
| – | – |
2020 Q2
20 quarters
|
|
61
Liberty Global Class A
LBTYA
$2.67B
| $115K | 0.03% |
11,495
| – | – |
2019 Q4
22 quarters
|
|
|
SMTK
62
SmartKem
SMTK
$549K
| $65.7K | 0.02% |
1,300
-2,033
| -61% | -$180K |
2024 Q4
2 quarters
|
|
63
ARK Blockchain & Fintech Innovation ETF
ARKF
$879M
| $60.3K | 0.01% |
1,200
| – | – |
2022 Q1
13 quarters
|
|
64
Revolution Medicines Inc Warrant
RVMDW
$90.6M
| $52.5K | 0.01% |
200,000
| – | – |
2023 Q4
6 quarters
|
|
65
Liberty Latin America Class C
LILAK
$1.57B
| $51.4K | 0.01% |
9,087
| – | – |
2020 Q2
20 quarters
|
|
66
ARK Next Generation Technology ETF
ARKW
$2.15B
| $44.3K | 0.01% |
300
| – | – |
2022 Q1
13 quarters
|
|
67
Alliance Entertainment Holding Corp Warrants
AENTW
| $36K | 0.01% |
200,000
| – | – |
2023 Q2
8 quarters
|
|
68
GeneDx Holdings
WGS
$1.87B
| $28.1K | 0.01% |
304
| – | – |
2021 Q3
15 quarters
|
|
|
69
Revolution Medicines
RVMD
$38B
| $20.5K | 0.01% |
556
| – | – |
2023 Q4
6 quarters
|
|
70
ARK Genomic Revolution ETF
ARKG
$1.98B
| $20.1K | ﹤0.01% |
825
| – | – |
2022 Q1
13 quarters
|
|
71
Starz Entertainment Corp
STRZ
$398M
| $17.5K | ﹤0.01% |
+1,092
| New | +$17.3K |
2025 Q2
0 quarters
|
|
72
Liberty Latin America Class A
LILA
$1.58B
| $12.3K | ﹤0.01% |
2,957
| – | – |
2020 Q1
21 quarters
|
|
73
DELISTED
ARKO Corp Warrant
ARKOW
| $4.23K | ﹤0.01% |
333,333
| – | – |
2020 Q4
18 quarters
|
|
74
SaverOne 2014 Ltd Warrant
SVREW
$63.2K
| $3.65K | ﹤0.01% |
121,000
| – | – |
2022 Q2
12 quarters
|
|
75
Aviat Networks
AVNW
$246M
| $1.59K | ﹤0.01% |
66
| – | – |
2020 Q2
20 quarters
|
|
Similar funds
NFW
SCM
PHC
EPM
BCM
FAM
WDG
OC
Bleichroeder LP's Q2 2025 Portfolio in Review
As of Q2 2025, Bleichroeder LP held 83 positions worth $407M, up 8.4% from $375M the previous quarter. Its ten largest holdings account for 82% of the portfolio.
Bleichroeder LP's Q2 2025 filing shows 5 new, 5 increased, 5 reduced and 7 closed positions. Its largest new stake was Welltower: 20,000 shares worth $3.07M. The largest sale was Intevac Inc, an estimated $20.1M.
By sector, the portfolio is most concentrated in Miscellaneous at 41% of assets, up from 41% a quarter earlier, followed by Industrials and Healthcare.
- Bleichroeder LP's largest Q2 2025 buy was Welltower: 20,000 shares worth $3.07M.
- Bleichroeder LP added most to Precision BioSciences in Q2 2025, an estimated $5.24M increase.
- Bleichroeder LP's biggest Q2 2025 reduction was SiriusXM, cutting an estimated $1.32M.
- Bleichroeder LP fully exited Intevac Inc in Q2 2025, selling an estimated $20.1M.
- Bleichroeder LP's ten largest holdings make up 82% of its $407M portfolio in Q2 2025.
- Bleichroeder LP opened 5 new positions and closed 7 in Q2 2025.
- Bleichroeder LP's portfolio value rose 8.4% quarter-over-quarter to $407M.
Based on Bleichroeder LP's 13F filing for Q2 2025, filed 14 Aug 2025.